-
Drugs
-
Common Technical Document (CTD) Modules/Sections Corresponding to Summary Data Tables in Bioequivalence Submissions to ANDAs
| Location of Summary Data Tables in Bioequivalence Submissions to ANDAs in eCTD and paper CTD | ||||
|---|---|---|---|---|
| Table | Name of Summary Data Table | Corresponding Module in eCTD | Corresponding Folder in eCTD | Corresponding Module/Section in paper CTD |
| 1 | Submission Summary | m2 | 27-clin-sum | 2.7.1.1. Background and Overview |
| 2 | Summary of Bioavailability Studies | m2 | 27-clin-sum | 2.7.1.3. Comparison and Analysis of Results Across Studies |
| 3 | Statistical Summary of the Comparative Bioavailability Data | m2 | 27-clin-sum | 2.7.1.3. Comparison and Analysis of Results Across Studies |
| 4 | Bioanalytical Method Validation | m2 | 27-clin-sum | 2.7.1.1. Background and Overview |
| 5 | Summary of In Vitro Dissolution Studies | m2 | 27-clin-sum | 2.7.1.2. Summary of Results of Individual Studies |
| 6 | Formulation Data | m2 | 27-clin-sum | 2.7.1.1. Background and Overview |
| 7 | Demographic Profile of Subjects Completing the Bioequivalence Study | m2 | 27-clin-sum | 2.7.4.1.3. Demographic and Other Characteristics of Study Population |
| 8 | Incidence of Adverse Events in Individual Studies | m2 | 27-clin-sum | 2.7.4.2.1.1. Common Adverse Events |
| 9 | Reanalysis of Study Samples | m5 52-tab-list 531-rep-biopharm-stud |
5314-bioanalyt-analyt-met study-report-no. |
5.3.1.4. Report of Bioanalytical and Analytical Methods for Human Studies |
| 10 | Study Information | m5 52-tab-list 531-rep-biopharm-stud |
5312-compar-ba-be-stud-rep study-report-no. |
5.3.1.2. Comparative Bioavailability and Bioequivalence Study Reports |
| 11 | Product Information | m5 52-tab-list 531-rep-biopharm-stud |
5313-in-vitro-in-vivo-corr-stud-rep study-report-no. |
5.3.1.3. In Vitro In Vivo Correlation Study Reports |
| 12 | Dropout Information | m5 52-tab-list 531-rep-biopharm-stud |
5312-compar-ba-be-stud-rep study-report-no. |
5.3.1.2. Comparative Bioavailability and Bioequivalence Study Reports |
| 13 | Protocol Deviations | m5 52-tab-list 531-rep-biopharm-stud |
5312-compar-ba-be-stud-rep study-report-no. |
5.3.1.2. Comparative Bioavailability and Bioequivalence Study Reports |
| 14 | Summary of Standard Curve and QC Data for Bioequivalence Sample Analyses | m5 52-tab-list 531-rep-biopharm-stud |
5314-bioanalyt-analyt-met study-report-no. |
5.3.1.4. Report of Bioanalytical and Analytical Methods for Human Studies |
| 15 | SOPs dealing with Bioanalytical Repeats of Study Samples | m5 52-tab-list 531-rep-biopharm-stud |
5314-bioanalyt-analyt-met study-report-no. |
5.3.1.4. Report of Bioanalytical and Analytical Methods for Human Studies |
| 16 | Composition of Meal Used in Fed Bioequivalence Study | m5 52-tab-list 531-rep-biopharm-stud |
5312-compar-ba-be-stud-rep study-report-no. |
5.3.1.3. Comparative Bioavailability and Bioequivalence Study Reports |
-
-

